Bioniche, Inc.

Calculating rank

USPTO Granted Patents = 4

Trademarks = 1

Forward Citations = 29

Loading Chart...

5 inventors (with patents filed for the assignee):

Stanley J Alkemade (4 out of 10 patents)

Alvaro Morales (3 out of 9 patents)

Dragan R Rogan (1 out of 2 patents)

4. Nigel C Phillips (1 out of 1 patent)

5. Catherine E Hildebrand (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 6139844 - Method for treating or eliminating a parasitic disease (2000-10-31),

2. 5888986 - Method for treating the urinary bladder and associated structures using (1999-03-30),

3. 5880108 - Method for treating the internal urinary bladder and associated (1999-03-09),

4. 5591724 - Method for treating the urinary bladder and associated structures using (1997-01-07),

Company Overview

Bioniche, Inc. is a biotechnology company focused on developing and commercializing innovative therapies for cancer treatment. Our mission is to improve patient outcomes and quality of life through cutting-edge research and development in the field of oncology. With a strong commitment to scientific excellence and patient care, we are dedicated to bringing groundbreaking treatments to market that have the potential to transform the way cancer is managed and treated worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

4 Patents

#39 in London

#3,474 in Canada

London, Canada

Bioniche, Inc.

Forward Citations = 29

5 inventors:

Stanley J Alkemade (4 out of 10 patents)

Alvaro Morales (3 out of 9 patents)

Dragan R Rogan (1 out of 2 patents)

4. Nigel C Phillips (1 out of 1 patent)

5. Catherine E Hildebrand (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bioniche, Inc.. Retrieved from https://idiyas.com/company/bioniche

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]